Search
Search Results
##search.searchResults.foundPlural##
-
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
4373Suppl. Files: 1222PDF: 1131Html: 273 -
CMV IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
4934PDF: 1862HTML: 2867Untitled: 254 -
LETERMOVIR PRIMARY CYTOMEGALOVIRUS PROPHYLAXIS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS: COULD INFECTION AND DISEASE NO LONGER BE A SIGNIFICANT PROBLEM? Letermovir and Cytomegalovirus Prophylaxis in HSCT
1608PDF: 1071HTML: 142 -
The ASSOCIATED FACTORS ON CYTOMEGALOVIRUS REACTIVATION OF CRITICALLY ILL IMMUNOCOMPETENT PATIENTS Cytomegalovirus Reactivation of Critically Ill Patients.
212PDF: 203HTML: 17 -
CYTOMEGALOVIRUS REACTIVATION IN ADULT RECIPIENTS OF AUTOLOGOUS STEM CELL TRANSPLANTATION: A SINGLE CENTER EXPERIENCE
1596PDF: 930HTML: 1019figures: 214table 1: 211table2: 212table3: 218 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4432PDF: 1243HTML: 2409Figure 1: 198 -
Toxic epidermal necrolysis associated with severe cytomegalovirus infection in a patient on regular hemodialysis.
1834PDF: 586HTML: 16995Figure 4: 193Figure 3: 163Figure 2: 169Figure 1: 205 -
CMV MANAGEMENT WITH SPECIFIC IMMUNOGLOBULINS: A MULTICENTRIC RETROSPECTIVE ANALYSIS ON 92 ALLOTRANSPLANTED PATIENTS. Anti-CMV immunoglobulins for CMV treatment
2652PDF: 1223HTML: 283 -
Acute Cytomegalovirus infection as a cause of venous thromboembolism
1640PDF: 881HTML: 1082Picture 1: 192 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
4592PDF: 1523HTML: 8538 -
Focusing On A Unique Innate Memory Cell Population Of Natural Killer Cells In The Fight Against COVID-19: Harnessing The Ubiquity Of Cytomegalovirus Exposure Memory Cell Population Of Natural Killer Cells in COVID-19 and Cytomegalovirus Exposure
1299PDF: 973HTML: 346 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1477PDF: 860HTML: 3138 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1530PDF: 1373HTML: 114 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3869PDF: 1649HTML: 864Figures . Eliassian: 255 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
977PDF: 715Suppl. Files: 144HTML: 156 -
Stroke in a patient with tuberculous meningitis and HIV infection
1777PDF: 850HTML: 1802figure 1: 187 -
Status Epilepticus Due to Severe HHV-6 Encephalitis in an Allogeneic Stem Cell Transplant Recipient
1234PDF: 866HTML: 2193Figue 1: 193 -
NURSING MANAGEMENT OF HAEMORRHAGIC CYSTITIS IN PATIENTS UNDERGOING HAEMATOPOIETIC STEM CELL TRANSPLANTATION: A MULTICENTRE ITALIAN SURVEY Nursing management of haemorrhagic cystitis
2077PDF: 1084HTML: 318 -
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome
1925PDF: 881HTML: 1643 -
NOVEL AGENTS AND EMERGING STRATEGIES FOR TARGETING THE B-CELL RECEPTOR PATHWAY IN CLL
2625PDF: 882HTML: 9061Efremov 1: 257Efremov 2: 219 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2244PDF: 1983HTML: 525 -
HEMATOLOGICAL ABNORMALITIES BEYOND LYMPHOCYTOSIS DURING INFECTIOUS MONONUCLEOSIS: EPSTEIN-BARR VIRUS-INDUCED THROMBOCYTOPENIA THROMBOCYTOPENIA DURING INFECTIOUS MONONUCLEOSIS
2303HTML: 654PDF: 1393 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
2998PDF: 1003HTML: 7498 -
A Rare Case of Rosai-Dorfman Disease in an Adult Male Associated with Auto-immune Hemolytic Anemia.
1447PDF: 960HTML: 1675Figure 1: 197 -
IMMUNOGLOBULIN GENE REPERTOIRE IN CHRONIC LYMPHOCYTIC LEUKEMIA: INSIGHT INTO ANTIGEN SELECTION AND MICROENVIRONMENTAL INTERACTIONS
3200PDF: 928HTML: 7306Kost Fig1: 213Kost Fig 2: 200Kost Fig3: 206Kost Fig 4: 218Kost Fig5: 217Kost fig 6: 204 -
Lymphomatoid Granulomatosis of Central Nervous System and Lung Driven by Epstein Barr Virus Proliferation: Successful Treatment with Rituximab
1702PDF: 948HTML: 3195Figure 5: 177Figure 4: 176Figure 3: 211Figure 1: 191Figure 2: 190







